Arie Zask

Affiliations: 
1982 Princeton University, Princeton, NJ 
Google:
"Arie Zask"
Mean distance: 7.45
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zask A, Ellestad GA. (2015) Recent Advances in Stereoselective Drug Targeting. Chirality
Zask A, Murphy J, Ellestad GA. (2013) Biological stereoselectivity of atropisomeric natural products and drugs. Chirality. 25: 265-74
Joshi D, Field J, Murphy J, et al. (2013) Synthesis of antioxidants for prevention of age-related macular degeneration. Journal of Natural Products. 76: 450-4
Zask A, Verheijen JC, Richard DJ. (2011) Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent review. Expert Opinion On Therapeutic Patents. 21: 1109-27
Richard DJ, Verheijen JC, Zask A. (2010) Recent advances in the development of selective, ATP-competitive inhibitors of mTOR. Current Opinion in Drug Discovery & Development. 13: 428-40
Zask A, Verheijen JC, Richard DJ, et al. (2010) Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 2644-7
Richard DJ, Verheijen JC, Yu K, et al. (2010) Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kalpha. Bioorganic & Medicinal Chemistry Letters. 20: 2654-7
Verheijen JC, Richard DJ, Curran K, et al. (2010) 2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stability. Bioorganic & Medicinal Chemistry Letters. 20: 2648-53
Niu C, Ho DM, Williamson RT, et al. (2010) Absolute configurations of tubulin inhibitors taltobulin (HTI-286) and HTI-042 characterized by X-ray diffraction analysis and NMR studies. Bioorganic & Medicinal Chemistry Letters. 20: 1535-8
Curran KJ, Verheijen JC, Kaplan J, et al. (2010) Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 1-substituent. Bioorganic & Medicinal Chemistry Letters. 20: 1440-4
See more...